The rising prevalence of infectious diseases has increased demand for simple, rapid in-vitro diagnostics (IVDs), resulting in a surge in public adoption of the lateral flow assay format in recent years. Lateral flow assays have several advantages compared to other technologies in the IVD field that they are inexpensive to produce, scalable, instrumentation-free to interpret, user-friendly without formal training, and capable of providing reliable results at home or in a laboratory setting. Rapid lateral flow test systems are easy-to-use, disposable diagnostic devices that can yield results in a short time (<30 minutes) by analyzing biomarkers in samples such as nasal swabs, saliva, blood, urine, and food.
Rapid Antigen Tests
Features
Workflow
Technical Specifications
Sample Types | Nasopharyngeal, anterior nasal and oropharyngeal swab specimens |
Shelf Life | 2 years |
Shipping / Storage | 2-30°C |
Operation Time | approx. 15 min |
Rapid Test Kits
2019 Novel Coronavirus (2019-nCoV), which belongs to the same family as the pathogen that causes severe acute respiratory syndrome (SARS), is first identified as the cause of a respiratory illness outbreak detected in Wuhan, China.
The main symptoms can include fever, cough, and difficulty breathing ranging from mild symptoms to severe illness and death. Cases of severe infection can result in pneumonia, kidney failure, and death.
Bosphore SARS-CoV-2 Rapid Antigen Test Kit is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.
This test is used only by professionals for the diagnosis of SARS-CoV-2 infection in clinical laboratories or for point-of-care testing. The test is not for personal use.
Kit Components
- Test Cassette
- Extraction Buffer
- Instructions for Use
- Disposable swab